Filtered By:
Infectious Disease: Flu Pandemic
Management: Centers for Disease Control and Prevention (CDC)
This page shows you your search results in order of date.
Order by Relevance | Date
Total 100 results found since Jan 2013.
Should I get a COVID-19 booster?
On 12 September, a vaccine advisory group to the Centers for Disease Control and Prevention (CDC) once again will wrestle with the question of who in the United States should receive a booster shot to protect against COVID-19.
As several new variants and an uptick in COVID-19 hospitalization fuel concerns among some health officials and the public, three companies have made new COVID-19 vaccines that can be used as a booster (or as primary doses for the unvaccinated). The Food and Drug Administration (FDA) is expected to approve at least one of these latest iterations before Tuesday’s meeting of CDC’s Advisory Com...
Source: Science of Aging Knowledge Environment - September 8, 2023 Category: Geriatrics Source Type: research
‘It’s still killing and it’s still changing.’ Ending COVID-19 states of emergency sparks debate
The World Health Organization (WHO) today declared an end to the emergency phase of the COVID-19 pandemic, days ahead of when a similar emergency in the United States is also set to expire. Both moves are likely to usher the world into a new phase of disease monitoring with a scaling back of surveillance and available resources to fight COVID-19.
WHO’s director-general, Tedros Adhanom Ghebreyesus, said at a press conference today in Geneva that WHO’s emergency committee met yesterday and recommended ending the Public Health Emergency of International Concern (PHEIC), the highest alert level WHO can declare, that h...
Source: Science of Aging Knowledge Environment - May 5, 2023 Category: Geriatrics Source Type: research
'It ’s still killing and it’s still changing.' Ending COVID-19 states of emergency sparks debate
The World Health Organization (WHO) today declared an end to the emergency phase of the COVID-19 pandemic, days ahead of when a similar emergency in the United States is also set to expire. Both moves are likely to usher the world into a new phase of disease monitoring with a scaling back of surveillance and available resources to fight COVID-19.
WHO’s director-general, Tedros Adhanom Ghebreyesus, said at a press conference today in Geneva that WHO’s emergency committee met yesterday and recommended ending the Public Health Emergency of International Concern (PHEIC), the highest alert level WHO can declare, that h...
Source: Science of Aging Knowledge Environment - May 5, 2023 Category: Geriatrics Source Type: research
Pandemic emergencies grind to a halt
The World Health Organization (WHO) today declared an end to the emergency phase of the COVID-19 pandemic, days ahead of when a similar emergency in the United States is also set to expire. Both moves are likely to usher the world into a new phase of disease monitoring with a scaling back of surveillance and available resources to fight COVID-19.
WHO’s director-general, Tedros Adhanom Ghebreyesus, said at a press conference today in Geneva that WHO’s emergency committee met yesterday and recommended ending the Public Health Emergency of International Concern (PHEIC), the highest alert level WHO can declare, that h...
Source: ScienceNOW - May 5, 2023 Category: Science Source Type: news
U.S. Will Lift Most Federal COVID-19 Vaccine Mandates Next Week
WASHINGTON — The Biden administration will end most of the last remaining federal COVID-19 vaccine requirements next week when the national public health emergency for the coronavirus ends, the White House said Monday.
Vaccine requirements for federal workers and federal contractors, as well as foreign air travelers to the U.S., will end May 11. The government is also beginning the process of lifting shot requirements for Head Start educators, healthcare workers, and noncitizens at U.S. land borders.
The requirements are among the last vestiges of some of the more coercive measures taken by the federal government to ...
Source: TIME: Health - May 2, 2023 Category: Consumer Health News Authors: Zeke Miller/AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news
Dispute simmers over who first shared SARS-CoV-2 ’s genome
When GISAID, the widely used database for influenza and SARS-CoV-2 genomes,
issued a statement
last week about a set of controversial sequences from the Huanan Seafood Wholesale Market in Wuhan, China, the release explained by way of background that the repository was “an essential contributor to global health” trusted by thousands of data contributors from 215 nations and territories. But GISAID also included a claim that has been puzzling and infuriating some virologists for 3 years: It was the place where the first SARS-CoV-2 genomes were publicly shared, on 10 January 2020.
That claim challenges contempo...
Source: Science of Aging Knowledge Environment - March 29, 2023 Category: Geriatrics Source Type: research
FDA Experts Vote to Make All COVID-19 Vaccines and Boosters Bivalent
In a unanimous decision, all 21 voting members of the U.S. Food and Drug Administration’s (FDA) vaccine committee recommended that the U.S. start using the same COVID-19 virus strain in all of the COVID-19 vaccines, including primary and booster doses.
That means the bivalent booster dose, which targets both the original SARS-CoV-2 strain and the Omicron BA.4/5 strains, would soon become the only type used for all primary shots and boosters.
The decision reflects a turning point in the pandemic. Until now, vaccine makers have tried to keep up with constantly evolving variants, but they’ve always been a few step...
Source: TIME: Health - January 27, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
What ’s next for COVID-19 vaccines? Scientists and regulators chart a course amid uncertainty
Just over 2 years ago, the first COVID-19 vaccines arrived—and a roller coaster ride of hope and science began. It soon became clear that although the vaccines protected against severe disease, their ability to fend off infection was limited and faded fast. Meanwhile, SARS-CoV-2 began to evolve rapidly to elude immunity. By now, many people have had four or five vaccine doses, including an updated booster tailored to Omicron strains that was introduced last fall.
Now, regulators and scientists are debating the near-term future. How often will we need booster doses and who should receive them? Should vaccines continu...
Source: Science of Aging Knowledge Environment - January 25, 2023 Category: Geriatrics Source Type: research
U.S. weighs crackdown on experiments that could make viruses more dangerous
.news-article__hero--featured .parallax__element{ object-position: 50% 40%; -o-object-position: 50% 40%; } .scroll-wrapper { overflow-x: auto; } .scroll-wrapper .news-article__figure__image{ width: 2680px; max-width: none; padding-bottom: .75rem; } .scroll-fade-before, .scroll-fade-after { position: absolute; width: 1.5rem; transition-duration: .1s; opacity: 1; } .scroll-fade-before { left: 1rem; /*margin-left: -1px;*/ background: linear-gradient(90deg, #fff, #fff 35%, hsla(0, 0%, 100%, 0)); } .scroll-fade-after { right: 1rem; /*margin-right: -1px;*/ background: linear-gradient(270deg, #fff, #fff 35%, hsla(0,...
Source: ScienceNOW - October 19, 2022 Category: Science Source Type: news
Researchers Are Now Tracking Monkeypox in Wastewater
If the past two years have taught us anything, it’s that testing for viral diseases is complicated. Sometimes, the tests are difficult to get, like in the early days of COVID-19. And even if people have access to testing, they might not feel they need it. People with COVID-19 often don’t have symptoms and may not always know to get tested. And now, with the availability of at-home self-tests, most people test themselves and don’t report the results. With other diseases—such as monkeypox—stigma surrounding the disease and the group most affected can deter access to testing.
These limitations hi...
Source: TIME: Health - September 7, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate monkeypox Source Type: news
Draft bill would ban CDC, NIH from funding lab research in China
A proposal moving through Congress to bar the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) from funding research laboratories in China is sparking concern among scientists. If signed into law, the measure could cut off millions of dollars of U.S. funds flowing to collaborative research projects in several areas, including HIV/AIDS, cancer, mental health, and flu surveillance.
The proposed ban, part of a 2023 spending bill approved by the U.S. House of Representatives Committee on Appropriations on 30 June, grew out of suspicions among some lawmakers, so far unsupported b...
Source: Science of Aging Knowledge Environment - July 12, 2022 Category: Geriatrics Source Type: research
COVID-19 Could Be Surging in the U.S. Right Now and We Might Not Even Know It
The rise of Covid cases in some regions of the U.S., just as testing efforts wane, has raised the specter that the next major wave of the virus may be difficult to detect. In fact, the country could be in the midst of a surge right now and we might not even know it.
Testing and viral sequencing are critical to responding quickly to new outbreaks of Covid. And yet, as the country tries to move on from the pandemic, demand for lab-based testing has declined and federal funding priorities have shifted. The change has forced some testing centers to shutter while others have hiked up prices in response to the end of government-...
Source: TIME: Health - April 11, 2022 Category: Consumer Health News Authors: MADISON MULLER / BLOOMBERG Tags: Uncategorized bloomberg wire COVID-19 healthscienceclimate Source Type: news
Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses
We present a short assessment based on a critical selection of evidence indicating nanotechnology's promise in the prevention and treatment of respiratory infections.PMID:34721558 | PMC:PMC8550859 | DOI:10.1155/2021/6741290
Source: PPAR Research - November 1, 2021 Category: Genetics & Stem Cells Authors: Mahdi Ftouh Nesrine Kalboussi Nabil Abid Souad Sfar Nathalie Mignet Badr Bahloul Source Type: research
